My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking

Dr Lal PathLabs is one of the largest companies in the Indian diagnostic industry, having a market share of 12.0% amongst diagnostic chains. It’s one of the fastest growing companies in the space with strong profitability. Dominant player in the industry: The company, according to our estimates, is the second largest player with an estima..

Alkem Laboratories (Alkem) is among the largest companies in the Indian formulation market, having a market share of 3.6%. The company is the fifth largest pharmaceutical company in India by domestic sales. Currently, domestic markets constitute around 75% of its sales; while in terms of exports, the company is at a relatively nascent sta..

S H Kelkar & Company Ltd (SHKCL) is the largest fragrance and flavour company in India by revenue, with a market share of approximately 12.0%. The company has four manufacturing facilities, three of which are located in India and one in The Netherlands, with a total installed manufacturing capacity of over 19,819 tonne annually. Estab..

Coffee Day Enterprises Ltd (CDEL) owns the coffee chain - Café Coffee Day, and is the largest coffee retail company in India. The company also has diversified business interests through its subsidiaries across segments like logistics, financial services, hospitality, and technology parks. Strong brand equity with a substantial market pres..

Company background: Sadbhav Infrastructure Project Ltd (SIPL) is a subsidiary of Ahmedabad-based Sadbhav Engineering Ltd (SEL). SIPL was incorporated in 2007 as a roads and highways operator. It has a portfolio of 10 BOT projects of which 6 road projects are fully operational, 1 is partially operational (border check posts) and 3 are unde..

Prabhat Dairy (Prabhat) is an integrated milk and dairy products company catering to institutional as well as retail customers. The company sells its products under retail consumer brands (which account for ~24% of the revenue) as well as ingredient products and co-manufactured products to a number of institutional and multinational compa..

Incorporated in 1993 as a subsidiary of Biocon Limited, Syngene is a leading custom research and manufacturing organization, which supports R&D programs from lead generation to clinical supplies. At the higher price band of Rs250/share, the implied P/E would be ~23x FY2017E compared to the average P/E of 17-22x for its global large pe..

Investment rationale: Capacity expansion to trigger growth: Currently the company has three manufacturing plants having a total capacity of around 9 lakh litres per day. The company is now setting up a new manufacturing facility in Haryana/Punjab, at a capex of around Rs152cr, which will increase the total capacity by around 50%. Going fo..